Olympus Announces FDA Clearance of RenaFlex™, Its First Single-use Flexible Ureteroscope
Posted:
Olympus Corporation single-use flexible ureteroscopy system, RenaFlex™, has received clearance from the U.S. Food and Drug Administration (FDA) and will soon be available in the United States.
This product assists in the diagnosis and treatment of urological conditions such as #Urolithiasis.
1 Day to Go!
AI In Healthcare: A Virtual Course
With Professor Shafi Ahmed & Dr Kim Oosthuizen
22 May 2025 | 09:30–16:30 (BST)
Earn 8 CPD points
Time is running out!
Tomorrow, we’re diving into how Artificial Intelligence is…
Biostate AI, a leading innovator in artificial intelligence and RNA sequencing, announced the successful completion of a $12M Series A funding round, led by Accel. The company’s immediate focus is revolutionizing RNAseq accessibility and developing clinically relevant predictive models.
Read more here.